Europe Medical Aesthetic Devices Market Size- By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Europe Medical Aesthetic Devices Market Introduction and Overview

According to SPER market research, 'Europe Medical Aesthetic Devices Market Size-By Type, By Application, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033'state that the Europe Medical Aesthetic Devices Market is predicted to reach with a CAGR of 11.67%.

Medical aesthetic devices are specialised equipment and instruments used in cosmetic procedures to improve people's physical appearance. These devices are intended to be less intrusive, providing non-surgical alternatives to typical cosmetic procedures. Medical aesthetic devices use technologies including laser, radiofrequency, ultrasound, and light-based therapies to target specific parts of the body and address a variety of cosmetic issues. These devices are used for a variety of procedures, such as skin rejuvenation, hair removal, body sculpting, and cosmetic augmentation.

The COVID-19 epidemic had a big impact on the European medical aesthetic devices market. During lockdowns, aesthetic clinics were temporarily closed, and non-essential procedures were suspended, causing the market to fall. However, as limitations were lifted and facilities reopened, demand for cosmetic operations began to recover. Patients wanted minimally intrusive treatments with shorter recovery times during the epidemic, emphasising the necessity of non-surgical therapies.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Type, By Application, By End User

Regions covered Belgium, France, Germany, Italy, Netherlands, Russia, Spain, Switzerland, The U.K., Turkey, Rest of Europe

Companies Covered Abbvie Inc (Allergan Inc.), Aerolase Corporation, Bausch Health Companies Inc. (Solta Medical Inc.), Cynosure, Cutera Inc., Galderma SA, Human Med AG, Johnson & Johnson (Mentor Worldwide), Lumenis Inc., Merz Pharma GmbH & Co. KGaA, Sciton Inc., Sisram Medical (Alma Lasers), Syneron Medical Ltd, Others.

Europe Medical Aesthetic Devices Market Segmentation:

By Type: Based on the Type, Europe Medical Aesthetic Devices Market is segmented as; Energy-Based Aesthetic Devices (Laser-based Aesthetic Devices, Light-based Aesthetic Devices, Radiofrequency (RF) Based Aesthetic Devices, Ultrasound Aesthetic Devices), Non-Energy-Based Aesthetic Devices (Botulinum Toxin, Chemical Peels, Dermal Fillers and Aesthetic Threads, Implants, Microdermabrasion, Other Aesthetic Devices).

By Application: Based on the Application, Europe Medical Aesthetic Devices Market is segmented as; Body Contouring and Cellulite Reduction, Breast Augmentation, Hair Removal, Skin Resurfacing and Tightening, Other Applications.

Product Code: MEDE2423

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Medical Aesthetic Devices Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Europe Medical Aesthetic Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Medical Aesthetic Devices Market

7. Europe Medical Aesthetic Devices Market, By Type (USD Million) 2020-2033

7.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Type, 2020-2026
7.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Type, 2027-2033
7.3. Energy-Based Aesthetic Devices
- 7.3.1. Laser-based Aesthetic Devices
- 7.3.2. Light-based Aesthetic Devices
- 7.3.3. Radiofrequency (RF) Based Aesthetic Devices
- 7.3.4. Ultrasound Aesthetic Devices
7.4. Non-Energy-Based Aesthetic Devices
- 7.4.1. Botulinum Toxin
- 7.4.2. Chemical Peels
- 7.4.3. Dermal Fillers and Aesthetic Threads
- 7.4.4. Implants
- 7.4.5. Microdermabrasion
- 7.4.6. Other Aesthetic Devices

8. Europe Medical Aesthetic Devices Market, By Application (USD Million) 2020-2033

8.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Application, 2020-2026
8.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By Application, 2027-2033
8.3. Body Contouring and Cellulite Reduction
8.4. Breast Augmentation
8.5. Hair Removal
8.6. Skin Resurfacing and Tightening
8.7. Other Applications

9. Europe Medical Aesthetic Devices Market, By End User (USD Million) 2020-2033

9.1. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By End User, 2020-2026
9.2. Europe Medical Aesthetic Devices Market Size, Share and Forecast, By End User, 2027-2033
9.3. Clinics
9.4. Hospitals
9.5. Other End-Users

10. Europe Medical Aesthetic Devices Market Forecast, 2020-2033 (USD Million)

10.1. Europe Medical Aesthetic Devices Market Size and Market Share

11. Europe Medical Aesthetic Devices Market, By Region, 2020-2033 (USD Million)

11.1. Europe Medical Aesthetic Devices Market Size and Market Share By Region (2020-2026)
11.2. Europe Medical Aesthetic Devices Market Size and Market Share By Region (2027-2033)
11.3. Belgium
11.4. France
11.5. Germany
11.6. Italy
11.7. Netherlands
11.8. Russia
11.9. Spain
11.10. Switzerland
11.11. Turkey
11.12. U.K.
11.13. Rest of Europe

12. Company Profile

12.1. Abbvie Inc (Allergan Inc)
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Aerolase Corporation
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Bausch Health Companies Inc. (Solta Medical Inc.)
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Cynosure
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Cutera Inc
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Galderma SA
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Human Med AG
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Johnson & Johnson (Mentor Worldwide)
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. Lumenis Inc
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. Merz Pharma GmbH & Co. KGaA
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Sciton Inc
- 12.11.1. Company details
- 12.11.2. Financial outlook
- 12.11.3. Product summary
- 12.11.4. Recent developments
12.12. Sisram Medical (Alma Lasers)
- 12.12.1. Company details
- 12.12.2. Financial outlook
- 12.12.3. Product summary
- 12.12.4. Recent developments
12.13. Syneron Medical Ltd
- 12.13.1. Company details
- 12.13.2. Financial outlook
- 12.13.3. Product summary
- 12.13.4. Recent developments
12.14. Others